1. Home
  2. CFFI vs DTIL Comparison

CFFI vs DTIL Comparison

Compare CFFI & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C&F Financial Corporation

CFFI

C&F Financial Corporation

N/A

Current Price

$74.38

Market Cap

242.9M

Sector

Finance

ML Signal

N/A

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$7.87

Market Cap

194.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFFI
DTIL
Founded
1927
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.9M
194.3M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
CFFI
DTIL
Price
$74.38
$7.87
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$45.00
AVG Volume (30 Days)
2.1K
186.6K
Earning Date
04-23-2026
05-14-2026
Dividend Yield
2.53%
N/A
EPS Growth
37.94
N/A
EPS
8.29
N/A
Revenue
$140,841,000.00
$1,070,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.94
N/A
Revenue Growth
10.63
N/A
52 Week Low
$58.00
$3.53
52 Week High
$80.99
$8.82

Technical Indicators

Market Signals
Indicator
CFFI
DTIL
Relative Strength Index (RSI) 44.10 63.56
Support Level $66.92 $4.56
Resistance Level $79.57 $8.82
Average True Range (ATR) 1.32 0.52
MACD -0.35 -0.01
Stochastic Oscillator 30.97 79.41

Price Performance

Historical Comparison
CFFI
DTIL

About CFFI C&F Financial Corporation

C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: